Publications by authors named "C Quivoron"

Claim this Profile
A
Association of immune relevant single nucleotide polymorphisms with ALK-positive anaplastic large cell lymphoma presentation and outcome: results of the immuno ALCL study.
Petrazzuolo Adriana, Vincent Carbonnier, Fatima Domenica Elisa De Palma, Maria Perez-Lanzon, Véronique Vergé, Cyril Quivoron

J Transl Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Notch pathway inhibition with crenigacestat (LY3039478) in a phase I first-in-human clinical trial for patients with relapsed or refractory non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia.
Jean-Marie Michot, Zsofia Balogh, Jennifer R Brown, Vincent Ribrag, Antoine Hollebecque, Cyril Quivoron

Ther Adv Drug Saf· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders.
David Fandrei, Jean Pegliasco, Florence Pasquier, Nathalie Ibrahim, Maria Kfoury, Cyril Quivoron

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience.
Claudia Parisi, José Carlos Benitez, Hélène Lecourt, Filippo Gustavo dall'Olio, Mihaela Aldea, Cyril Quivoron

J Liq Biopsy· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study.
C Quivoron, J-M Michot, A Danu, H Lecourt, V Saada

Leuk Lymphoma· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis